GGrantIndex
← Leaderboards

Omneuron, Inc.

Menlo Park, CA

Compare ↔
$17,105,950
Total funding
14
Grants

Funding over time

peak $4.8M · FY200515
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$17,105,950 · 14

By mechanism

R44$10,418,445 · 3
N44$3,674,720 · 2
R43$2,515,246 · 7
N43$497,539 · 2

Investigators at Omneuron, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Largest grants

SBIR Phase II Contract N44DA8-4408 - Development of a Real-Time fMRI Feedback Sy$1,874,252
N44 · FY2008 · DA
Treatment of Chroinc Pain Using Real Time Functional MRI$1,373,330
R44 · FY2009 · NS
Treatment of Chroinc Pain Using Real Time Functional MRI$1,364,306
R44 · FY2008 · NS
Treatment of Chroinc Pain Using Real Time Functional MRI$1,290,942
R44 · FY2007 · NS
MEASUREMENT AND CONTROL OF PATTERNED BRAIN ACTIVATION USING REAL TIME FMRI$1,207,313
R44 · FY2008 · DA
Opoid Misuse, Chronic Pain and Real Time fMRI$1,199,832
N44 · FY2009 · DA
MEASUREMENT AND CONTROL OF PATTERNED BRAIN ACTIVATION USING REAL TIME FMRI$1,188,828
R44 · FY2009 · DA
APPLICATIONS OF REAL TIME FMRI - PHASE II$659,001
R44 · FY2004 · NS
APPLICATIONS OF REAL TIME FMRI - PHASE II$659,001
R44 · FY2005 · NS
APPLICATIONS OF REAL TIME FMRI - PHASE II$659,001
R44 · FY2006 · NS
Opoid Misuse, Chronic Pain and Real Time fMRI$600,636
N44 · FY2010 · DA
REAL-TIME FMRI TECHNOLOGY ENABLING A NOVEL TREATMENT MODALITY IN DEPRESSION$497,821
R44 · FY2012 · MH
REAL-TIME FMRI TECHNOLOGY ENABLING A NOVEL TREATMENT MODALITY IN DEPRESSION$497,821
R44 · FY2013 · MH
REAL-TIME FMRI TECHNOLOGY ENABLING A NOVEL TREATMENT MODALITY IN DEPRESSION$497,821
R44 · FY2011 · MH
Opioid Misuse, Chronic Pain and Real-time fMRI$347,539
N43 · FY2008 · DA
Web-Based treatment for chronic pain$330,968
R43 · FY2013 · DA
Web-Based treatment for chronic pain$308,678
R43 · FY2014 · DA
REAL-TIME FMRI TECHNOLOGY ENABLING A NOVEL TREATMENT MODALITY IN DEPRESSION$299,024
R44 · FY2010 · MH
COMPOUNDS TARGETING THE ALPHA-2 GABA-A RECEPTOR SUBTYPE$250,000
R43 · FY2006 · MH
COMPOUNDS TARGETING THE ALPHA-2 GABA-A RECEPTOR SUBTYPE$250,000
R43 · FY2005 · MH
Omneuron, Inc. · GrantIndex